Suscribirse

Clinical profile and outcome of non-HIV-infected patients with cryptococcal meningitis and malignancy - 17/08/22

Doi : 10.1016/j.mycmed.2022.101250 
Xiaofeng Xu a, 1, Liping Cao b, 1, Yijie Wang a, Jia Liu a, Qing Dong a, Chunling Liang c, Ying Jiang a, , Fuhua Peng a, 2
a Department of Neurology, The Third affiliated Hospital of Sun Yat-sen University, Guangzhou, 510530, P. R. China 
b Department of Neurology, The First Affiliated Hospital of Guizhou University of traditional Chinese Medicine, Guiyang, 550001, P. R. China 
c Department of Medical Records, The Third affiliated Hospital of Sun Yat-sen University, Guangzhou, 510530, P. R. China 

Corresponding author at: Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, Guangdong 510630, China.Third Affiliated Hospital of Sun Yat-Sen University600 Tianhe RoadGuangzhouGuangdong510630China

Abstract

Background

Cryptococcal meningitis (CM) can coexist with malignancy in patients not infected by human immunodeficiency virus (HIV). The purpose of this study was to evaluate the clinical characteristics and therapeutic outcomes of non-HIV-infected patients with CM with malignancy.

Methods

The study cohort comprised 320 patients diagnosed with CM from January 2013 to May 2019. Malignancy was diagnosed based on the medical history, imaging findings, and pathological findings. One-hundred-and-four patients also underwent positron emission computed tomography (PET-CT) examination to enable the early detection of possible malignancies. The demographics, clinical characteristics, and outcomes were analyzed.

Results

Twelve patients with CM with malignancies were found. Seven were patients with CM who had a history of malignancies (CM in malignancy; CIM), while five patients had malignancies detected after being diagnosed with CM (malignancy in CM; MIC). The patients with CM with malignancies, especially MIC, were older than those without malignancies. The outcome was similar for patients with CIM and patients with CM without malignancy, but was extremely poor for patients with MIC. PET-CT examination suggested malignancy in five of 104 patients, with malignancy finally confirmed in four of five patients.

Conclusions

Compared with the general population, the rate of solid malignancies was increased in patients with CM, especially older adults. The presence of malignancies and timing of discovery were closely related to the outcome of patients with CM. Thus, it is necessary to screen for malignancies in older adults with CM. PET-CT might be useful for early malignancy screening of patients with CM.

El texto completo de este artículo está disponible en PDF.

Keywords : Cryptococcal meningitis, Malignancy, Positron emission computed tomography, Non-HIV-infected patients


Esquema


© 2022  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 32 - N° 3

Artículo 101250- août 2022 Regresar al número
Artículo siguiente Artículo siguiente
  • Antifungal effect of hydroethanolic extract of Fridericia chica (Bonpl.) L. G. Lohmann leaves and its therapeutic use in a vulvovaginal candidosis model
  • William Gustavo Lima, Marcelo Gonzaga Freitas Araújo, Júlio César Moreira Brito, Rachel Oliveira Castilho, Valbert Nascimento Cardoso, Simone Odília Antunes Fernandes

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.